Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TAKAHASHI, H.
Right arrow Articles by SHIRASU, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by TAKAHASHI, H.
Right arrow Articles by SHIRASU, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Potentiations of N-Methylcarbamate Toxicities by Organophosphorus Insecticides in Male Mice1

HIROAKI TAKAHASHI, AYAKO KATO, ERIKO YAMASHITA, YOKO NAITO, SHUJI TSUDA and YASUHIKO SHIRASU

Mitsukaido Laboratories, Institute of Environmental Toxicology 4321 Uchimoriya, Mitsukaido, Ibaraki 302-02, Japan

Potentiations of N-Methylcarbamate Toxicities by Organophosphorus Insecticides in Male Mice. TAKAHASHI, H., KATO, A., YAMASHITA, E., NAITO, Y., TSUDA, S., and SHIRASU, Y. (1987). Fundam. Appl. Toxicol. 8, 139–146. A N-methylcarbamate insecticide, 2-sec-butylphe-nyl N-methylcarbamate (BPMC), is markedly potentiated by low-dose treatments of P=S type organophosphorus insecticides. As a mechanism of this potentiation, the increase of plasma BPMC concentrations due to the inhibited metabolic degradation has been suggested. In this study, acute toxicities of five N-methylcarbamates structurally related to BPMC were studied after low-dose treatments of three P=S type organophosphorus insecticides (cyanophos, feni-trothion, and malathion) and one P=O type organophosphorus insecticide (dichlorvos), and the role of plasma concentrations of N-methylcarbamates in the potentiations was examined. Acute toxicities of five N-methylcarbamates were potentiated by the treatments of the P=S types, among which the potentiation of BPMC was strongest. BPMC toxicity was not potentiated by the treatment of the P=O type. Plasma concentrations of BPMC were increased by the treatments of the P=S types, but not by the treatment of the P=O type. The acute toxicity and plasma concentrations of BPMC were increased by SKF 525-A (an inhibitor of mixed-function oxidase). These results suggest that the increase of plasma BPMC concentrations may be related to the potentiation of BPMC toxicity. The treatment of fenitrothion increased plasma concentrations of other N-methylcarbamates more than those of BPMC, although the potentiation of BPMC toxicity was strongest. SKF 525-A and fenitrothion treatments increased plasma BPMC concentrations to a similar degree, but the potentiation of BPMC toxicity by SKF 525-A was significantly less than that by fenitrothion. Thus, some other mechanism(s) may be responsible for the potentiations of the N-methylcarbamate toxicities.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.